Financial Tearsheet






Financial Tearsheet

Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

News Releases

08 Aug 19
Cronos Group Inc. Announces Second Quarter and First-Half 2019 Results
Opened Cronos Device Labs , New Global R&D Center in Israel Appointed Dr. Todd Abraham as Chief Innovation Officer Announced Agreement to Acquire State-of-the-Art Fermentation Facility Established New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform  TORONTO
02 Aug 19
Cronos Group Establishes New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform
TORONTO , Aug. 02, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it has entered into a definitive agreement to acquire four of Redwood Holding Group , LLC’s operating subsidiaries (collectively, “ Redwood ”).
11 Jul 19
Cronos Group Enters Agreement to Acquire State-of-the-Art Fermentation and Manufacturing Facility
Facility Advances Partnership with Ginkgo Bioworks;  Will Enable Production of Cultured Cannabinoids at Commercial Scale TORONTO , July 11, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it has entered into an

SEC Filings

Filing date Description

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Events

13 November 2018 at 8:30 AM EST
Third Quarter 2018 Earnings Conference Call
14 August 2018 at 8:00 AM EDT
Second Quarter 2018 Earnings Conference Call
04 March 2018 at 8:30 AM EST
Landmark Partnership with Ginkgo Bioworks Conference Call